Background and Purpose-Native Hawaiians and other Pacific Islanders (NHOPI) with ischemic stroke have younger age of stroke onset compared with whites. However, ethnic differences in stroke subtypes in this population have been inadequately studied. Methods-Consecutive young adult patients (aged ≤55 years) who were hospitalized for ischemic stroke between 2006 and 2012 at a tertiary center in Honolulu were studied. Clinical characteristics and stroke subtypes based on pathophysiological TOAST classification (Trial of Org 10172) of NHOPI and Asians were compared with whites. Results-A total of 427 consecutive young adult (mean age, 46.7±7.8 years) patients (NHOPI 45%, Asians 38%, and whites 17%) were studied. NHOPI had a higher prevalence of hypertension, diabetes mellitus, prosthetic valve, higher body mass index, hemoglobin A1c, and lower high-density lipoprotein than whites (all P<0.05). Stroke subtype distribution was not different between the ethnic groups. Specifically, the prevalence of small-vessel disease was similar between NHOPI (26.6%), whites (28.4%), and Asians (24.8%). In the univariate analyses, the use of intravenous tissuetype plasminogen activator was lower among NHOPI (4.7%; P=0.01) and Asians (3.1%; P=0.002) than among whites (12.5%). In the multivariable model, NHOPI (odds ratio, 0.35; 95% confidence interval, 0.12-0.98) and Asians (odds ratio, 0.23; 95% confidence interval, 0.07-0.74) were less likely to be treated with intravenous tissue-type plasminogen activator than whites. Conclusions-NHOPI have greater cardiovascular risk factors than whites, but there were no differences in stroke subtypes between the ethnic groups. Furthermore, NHOPI and Asians may be less likely to be treated with intravenous tissue-type plasminogen activator than whites.
M
inorities have been shown to have a higher burden of stroke, [1] [2] [3] younger age of stroke onset, [3] [4] [5] worse stroke outcome, 6, 7 and different distribution of ischemic stroke subtypes compared with whites. [8] [9] [10] Specifically, higher proportion of small-vessel disease (SVD)/lacunar stroke and intracranial atherosclerosis have been described among minorities. [9] [10] [11] [12] Establishing these disparities in ischemic stroke subtypes is important in understanding the predominant stroke mechanism among the high-risk ethnic group, which may result in more focused primary and secondary stroke prevention strategy for that community. 13 Large-vessel disease may be more amenable to antiplatelet and statin therapies and revascularization procedure; fibrin-rich thrombus formation in cardioembolic stroke may be better treated with anticoagulants; SVD from arteriosclerosis may require more intensive treatment for the underlying risk factors such as hypertension and diabetes.
14 Among the young stroke population, atypical risk factors and other systemic medical conditions associated with ischemic stroke may also need to be addressed. 15 Importantly, the risk of recurrent stroke after the initial stroke is different based on the ischemic stroke subtypes. 16 Previous studies that compared ethnic differences in ischemic stroke subtypes have mainly focused on blacks and Hispanics. Unfortunately, native Hawaiians and other Pacific Islanders (NHOPI) with strokes have been largely understudied because NHOPI have been historically aggregated with Asians into a single ethnic group in most previous studies. As a combined ethnic group, Asians and NHOPI may have age-specific stroke mortality that is 1.5× higher than those of whites. 17 Also, NHOPI have been reported to have a higher prevalence of major cardiovascular risk factors 18 and die at a younger age from cardiovascular diseases compared with other racial-ethnic groups in Hawaii. 19 Compared with the general US population, NHOPI have also been reported to have lower levels of physical activity and higher prevalence of obesity and cardiometabolic conditions. 18 A recent study demonstrated that NHOPI with ischemic strokes are more than a decade younger, and they have a higher burden of cardiovascular risk factors compared with whites. Despite the overwhelming evidence of cardiovascular health disparities among NHOPI, the ethnic differences in ischemic stroke subtype in this population have not been assessed. We, therefore, conducted a retrospective study, exclusively on young adult stroke population in Hawaii, and compared the ischemic stroke subtypes and clinical characteristics of NHOPI and Asians with whites. We hypothesized that among the young adult stroke population, NHOPI have a higher proportion of SVD from early onset of hypertension and diabetes mellitus compared with whites.
Methods
We received approval from the Queen's Medical Center (QMC) Research and Institutional Review Committee to conduct a singlecenter, retrospective study of young adults (aged ≤55 years) who were hospitalized at the QMC between 2006 and 2012 with admission diagnosis of ischemic stroke. Waiver of consent was obtained to conduct this study. QMC is a 505-bed medical center located on Oahu, the largest hospital in Hawaii and the tertiary referral center for the Pacific Basin (Hawaii, American Samoa, the Commonwealth of the Northern Mariana Islands, Micronesia, and the US territories of Guam). During the study period, QMC was the only Joint Commission-certified Primary Stroke Center for the state of Hawaii. Currently, ≈500 cases of ischemic stroke are admitted to QMC per year, with an ethnic distribution that is representative of the general population in Hawaii.
All adult patients who were aged ≤55 years and were hospitalized at QMC between January 1, 2006, and August 31, 2012, with a diagnosis of ischemic stroke were identified using the institutional stroke database. To capture all patients with ischemic stroke hospitalized at QMC, a dedicated stroke database coordinator screens the entire hospital census on a daily basis with medical record review of appropriate cases. Patients with admission diagnosis of ischemic stroke is confirmed by imaging study reports or by clinical documentation confirming the neurological deficits that are consistent with the diagnosis of stroke. Patients with admission diagnosis of other neurological symptoms (ie, altered mental status, dizziness, and generalized weakness) are also carefully reviewed to ensure that no stroke cases are missed. The stroke database coordinator also gets notified for any in-hospital stroke code. Furthermore, majority of patients with stroke are admitted to a dedicated stroke/neuro floor or transferred to this floor when the stroke is later discovered, which increases the yield of screening process. All ischemic strokes presenting during this period were included. Patients who had ischemic stroke from procedural or surgical complication were excluded.
Baseline Characteristics
Baseline demographic and clinical characteristics, including known risk factors and administration of intravenous tissue-type plasminogen activator (tPA), were obtained from a manual chart review process. The ethnicity information was collected from the hospital's administrative database and were obtained during the registration or admission process according to a standard institutional protocol. Because of the low number of blacks and American Indian/Alaska natives, these ethnic groups were combined with the other group. For this study, ethnicity was categorized as NHOPI, Asian, white, or other. Because mixed ethnic background is relatively common in Hawaii, ethnicity was defined as the ethnic background that the patient most closely associated with and was based on patient self-identification or family's identification if the patient was incapacitated. Additional data on body mass index, hemoglobin A1c, total cholesterol, lowdensity lipoprotein, high-density lipoprotein, and triglycerides were also collected if they were available. Newly diagnosed atrial fibrillation was defined as newly detected atrial fibrillation on telemetry monitoring or ECG with absence of clinical history before hospitalization. Newly diagnosed atrial fibrillation was not included in the descriptive summary of known risk factors.
Outcome Measures
Ischemic stroke subtype was the clinical outcome measure for this study. One investigator (K.N.) subtyped all patients using clinical data that had been collected, with additional review of all original neuroimaging including brain computed tomography, magnetic resonance imaging, computed tomography or magnetic resonance angiography and cerebral angiogram, and original notes when necessary. Subtyping was not fully blinded to ethnicity because names were apparent on the neuroimaging reviewing system. The pathophysiological TOAST (Trial of Org 10172) subtyping classification was used. 20 SVD was defined as a clinical lacunar syndrome with classic lesion on magnetic resonance imaging or computed tomography. Large-vessel disease was defined as carotid, vertebral, or major intracranial artery stenosis >50% in the arterial territory of the stroke. Cardioembolic stroke was based on the presence of a potential source of cardiac embolism (ie, atrial fibrillation/flutter, intracardiac thrombus, prosthetic valves, or patent foramen ovale with right-to-left shunt with no other cause to account for). All other known causes of stroke, such as bacterial endocarditis, cerebral vasculitis, and carotid and vertebral artery dissection, and other rare causes of stroke were designated as other. When no cause of stroke was found, patients were assigned to an unknown category. If the neuroimaging had findings that were highly suggestive of embolic stroke cause, but there were no other data supporting the cardioembolic source, it was assigned as unknown.
Statistical Analysis
Data were analyzed using commercially available statistical software (SPSS 23.0; Chicago, IL). We excluded patients identified as other ethnicity. For primary analyses, NHOPI were compared with whites; for secondary analyses, Asians were compared with whites. Patient characteristics and ischemic stroke subtypes of the 2 groups were compared using the χ 2 test for categorical data, and 2-tailed t test for normally distributed continuous variables. Multivariable analyses using a logistic regression model were performed to calculate odds ratio (OR) and 95% confidence interval (CI). Age, sex, primary language (non-English versus English), hypertension, diabetes mellitus, hypercholesterolemia, atrial fibrillation/flutter, and smoking were included in the models. Because the univariate analysis showed ethnic differences in the treatment rate of intravenous tPA, similar multivariable analyses were performed to assess the impact of ethnicity on intravenous tPA treatment rate. Before initiating the study, a sample size calculation was performed, which determined that 448 patients (estimating 179 NHOPI and 80 whites) were needed to detect a 15% difference in the prevalence of SVD between NHOPI and whites with a power of 0.80 and 2-sided α of 0.05.
Results
Between January 2006 and December 2012, a total of 451 consecutive young adult patients hospitalized for ischemic stroke were identified. Twenty-four patients with other ethnicity and 2 patients with missing ethnicity data were excluded, resulting in a total of 427 patients (NHOPI 45%, Asians 38%, and whites 17%) who were included in the analyses. Unadjusted analyses (Table 1) showed that NHOPI were more likely to be women, married, and non-English speaking and were more likely to have hypertension, diabetes mellitus, prosthetic valve, higher low-density lipoprotein, lower highdensity lipoprotein, higher body mass index, and hemoglobin A1c than whites. NHOPI were also less likely to receive intravenous tPA treatment than whites. Asians were more likely to be non-English speaking and have higher total cholesterol and low-density lipoprotein and were also less likely to receive intravenous tPA treatment than whites.
Differences in stroke subtype between the NHOPI and whites and Asians and whites are shown in 
Discussion
In this study of young adult patients with ischemic strokes, NHOPI represented 45% of the patient population, which is substantially higher than the NHOPI representation in the community (26%) 21 and supports the idea that NHOPI have a relatively younger age of onset for ischemic stroke. Contrary to our initial hypothesis, this study demonstrates that the distributions of ischemic stroke subtypes among the young adult population in Hawaii are similar between NHOPI, Asians, and whites. Because NHOPI have a higher burden of hypertension, diabetes mellitus, hyperlipidemia, and obesity even at younger age than whites and Asians as shown in this study, we had initially expected the NHOPI to have a higher prevalence of SVD-related strokes compared with whites and Asians and whites and Asians with less cardiovascular risk factors to have a higher proportion of atypical causes of stroke (ie, carotid or vertebral artery dissection, cerebral vasculitis, and hematologic disorder). This was based on the previous studies that suggested a higher proportion of SVD, intracranial atherosclerosis, and hypertension in blacks compared with whites, possibly because of their high burden of hypertensive disease. 9, 11, [22] [23] [24] [25] Even though our study demonstrated a similar finding of high burden of hypertension among NHOPI, similar to the blacks in other studies, the prevalence of SVD was not much higher than whites. Rather, NHOPI seem to have an earlier onset of ischemic stroke without any predilection for a specific ischemic stroke subtype.
The findings from our study is important in that it may shift the conceptual framework of how we understand the causes of stroke disparities among NHOPI. Anecdotally, many clinicians practice with the assumption that much of the early ischemic strokes among NHOPI may be driven by SVD/ lacunar strokes from uncontrolled hypertension and diabetes mellitus. However, given our study findings, we may need to further emphasize the importance of searching for other stroke causes including large-vessel disease, cardioembolism, and other atypical causes of ischemic stroke in this ethnic group. In fact, racial/ethnic differences in the care for patients with atrial fibrillation have been reported. 26 Perhaps, similar disparities for the anticoagulation management for atrial fibrillation and valvular disease may also exist among NHOPI whom had 26% cardioembolic strokes. This study also emphasizes the concept that disparities patterns may not always be the same across all minority groups; and highlights the importance of exploring for the possibility of unexpected clinical characteristics that may exist in an understudied, multiethnic community.
Moreover, our study suggests the possibility of disparities in intravenous tPA treatment rate among the young adults in Hawaii. Potential factors that may explain the lower rates of intravenous tPA treatment among NHOPI and Asians include differences in the (1) public awareness of stroke signs and symptoms that may delay the arrival to the emergency department, (2) modes of transportation to the emergency department, (3) geographic distance from the stroke center, (4) 
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language barrier that could result in inappropriate triage by the emergency department staff or inaccurate assessment of the time last seen well, (5) proportion of minor strokes, and (6) use of oral anticoagulants. Unfortunately, our study was not designed to assess these potential confounding factors, and thus our results on intravenous tPA differences should be interpreted with caution. Further study is needed to determine the contributing factors for our preliminary observation. Strengths of our study include the detailed clinical and radiographic assessment of ischemic stroke subtypes among the multiethnic young adult population in Hawaii, which has not been done previously. However, there are some limitations to the study. More recent studies suggest that disparities in cardiovascular risk factors are primarily related to socioeconomic status, and less to race/ethnicity. 27 Unfortunately, the data on socioeconomic status were not available in our study, and thus we were unable to assess its impact on the observed disparities. Also, prehospital medication adherence could not be assessed from our retrospective study, which may have impacted our results. Furthermore, stroke severity measures such as National Institutes of Health Stroke Scale were not documented in most of our patients and could not be included in the final model. Because of the single-center study design, our results may not be generalizable to other populations. Overall, our institution captures ≈ 21% of all ischemic stroke hospitalization for the state of Hawaii (data from Hawaii Health Information Corporation). Because our institution is a tertiary referral center, there may have been a referral bias toward more severe stroke patients with more extensive comorbidities or atypical causes of stroke. Although we acknowledge the limitation of a single-center study, we believe that this is an important first glance of stroke subtype distributions among the young adult patients with ischemic stroke in Hawaii.
Conclusions
In a retrospective study of young adult stroke population in Hawaii, we found no ethnic differences in ischemic stroke subtypes between NHOPI, Asians, and whites. Specifically, we found no relative excess of SVD among NHOPI compared with that among whites. Among young adults with ischemic stroke, NHOPI and Asians may be less likely to be treated with intravenous tPA compared with whites. However, the ethnic differences in intravenous tPA treatment rate are a preliminary observation, and further study is needed to confirm this finding.
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